| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $316.3M | +4.2% |
| Cost of Revenue | $108.5M | +0.0% |
| Gross Profit | $207.8M | +6.5% |
| R&D Expense | $39.5M | -17.0% |
| SG&A Expense | $116.5M | +25.7% |
| Operating Income | $4.6M | -70.2% |
| Pre-tax Income | -$28.9M | -55.2% |
| Income Tax | $908K | -96.2% |
| Net Income | -$29.8M | +30.0% |
| EPS (Basic) | -$0.39 | +26.4% |
| EPS (Diluted) | -$0.39 | +26.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.8M | +15.3% |
| Accounts Receivable | $34.4M | +13.6% |
| Current Assets | $138.2M | +11.0% |
| Total Assets | $961.3M | -3.5% |
| Current Liabilities | $57.0M | +2.1% |
| Long-term Debt | $468.6M | +10.6% |
| Total Liabilities | $533.8M | +9.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $77.8M | +14.5% |
| Capital Expenditures | $367K | -61.1% |
| Investing Cash Flow | -$7.5M | -137.0% |
| Financing Cash Flow | -$58.0M | +8.5% |
| Free Cash Flow | $77.4M | +15.5% |
| Stockholders' Equity |
| $427.5M |
| -15.9% |